Wednesday, November 09, 2011 6:46:41 PM
Published on Wed, 11/09/2011 - 13:03
Today, shares of Edwards Lifesciences (NYSE:EW) have crossed bearishly below their 10-day moving average of $75.47 on a volume of 349K shares. This may provide short-term investors a chance for a short position, as such a crossover often suggests lower prices in the near term.
Edwards Lifesciences (NYSE:EW) has potential upside of 16.2% based on a current price of $74.09 and analysts' consensus price target of $86.12. Edwards Lifesciences shares should encounter resistance at the 200-day moving average (MA) of $81.16 and support at the 50-day MA of $73.55.
Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
Over the past year, Edwards Lifesciences has traded in a range of $61.63 to $91.82 and is now at $74.09, 20% above that low. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.3%.
Recent EW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 12:17:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 09:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 10:06:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 11:10:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:34:20 PM
- Edwards Lifesciences Completes Sale of Critical Care • Business Wire • 09/03/2024 08:30:00 PM
- CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves • Business Wire • 08/31/2024 10:58:00 PM
- First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves • Business Wire • 08/31/2024 04:35:00 PM
- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference • Business Wire • 08/21/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 11:42:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/20/2024 09:12:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:33:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 09:58:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/14/2024 08:19:52 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/31/2024 08:20:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 08:14:58 PM
- Earnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5% • IH Market News • 07/25/2024 10:19:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 08:26:30 PM
- Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix • Business Wire • 07/24/2024 08:15:00 PM
- Edwards Lifesciences Reports Second Quarter Results • Business Wire • 07/24/2024 08:15:00 PM
- Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024 • Business Wire • 07/17/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 01:04:03 PM
- Edwards Lifesciences to Acquire Innovalve • Business Wire • 07/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:38:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 08:17:18 PM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM